(IN BRIEF) Novartis has confirmed its plans for a full Spin-off of its Sandoz business, with trading of new Sandoz Group AG shares and ADRs scheduled to begin on October 4, 2023. This comes after receiving shareholder approval and key … Read the full press release
Posted in Business, Financial, Investment, Pharma & Biotech, Switzerland
Tagged ADRs, American Depositary Receipts, Novartis, Novartis ADR, OTCQX®, Sandoz, Sandoz Group AG, SDZ, shareholder, shares, SIX Exchange Regulation, SIX Swiss Exchange, SLI®, spin-off, SPI®, Swiss indices, Swiss Leader Index, Swiss Performance Index
(IN BRIEF) Merck, a prominent science and technology company, has announced strategic drug discovery collaborations with AI technology firms BenevolentAI and Exscientia. These partnerships aim to leverage AI-driven design and discovery capabilities to advance research efforts in key therapeutic areas, … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AI, AI-Driven Drug, BenevolentAI, Danny Bar-Zohar, data, Exscientia, immunology, Merck, Neurology, oncology, partnership, science
(IN BRIEF) Alexion, in collaboration with AstraZeneca Rare Disease, has finalized an agreement to acquire a collection of preclinical rare disease gene therapy programs and related technologies from Pfizer Inc. This strategic move combines the expertise of Alexion and AstraZeneca … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, United Kingdom
Tagged acquisition, Adrian Kemp, Alexion, AstraZeneca, AstraZeneca Rare Disease, gene therapy, genomic medicine, partnership, Pfizer
(IN BRIEF) Medidata, a subsidiary of Dassault Systèmes, has introduced the Medidata Diversity Program, an extensive solution aimed at enhancing diversity, equity, and inclusion in clinical trials. This program supports biopharmaceutical companies, medical device firms, and clinical research organizations (CROs) … Read the full press release
(IN BRIEF) BioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) have entered into a strategic partnership to develop an mRNA-based vaccine, BNT166, for the prevention of mpox (formerly monkeypox), an infectious disease that can have severe and life-threatening complications. … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Norway, Pharma & Biotech, Science
Tagged BioNTech, BNT166, CEPI, mpox Prevention, mRNA-Based Vaccine, partnership, Prof. Ugur Sahin, Richard Hatchett, sustainability
(IN BRIEF) Pharmaceutical company GSK and international non-profit organization Save the Children have renewed their partnership for another five years, with GSK committing £15 million to the initiative. The collaboration will primarily focus on increasing child vaccination rates and reducing … Read the full press release
Posted in Business, Government, Healthcare, Industrial, Management, News, Non Profit, Pharma & Biotech, Science, Security & Safety, Society, United Kingdom
Tagged Child Vaccination Rates, Dr Thomas Breuer, Dr. Lia Tadesse, ETHIOPIA, GSK, Nigeria, partnership, Save the Children, Xavier Joubert, Zero dose children
(IN BRIEF) An international team of researchers has released a scientific paper through the IDAlert project, published in The Lancet Regional Health – Europe journal on August 7, 2023. Titled “Decision-Support Tools to Build Climate Resilience Against Emerging Infectious Diseases … Read the full press release
Posted in Environment, European Union, Healthcare, News, Pharma & Biotech, Science, Society
Tagged climate change, climate-driven health risks, climate-sensitive infectious diseases, Emerging Infectious Diseases, Horizon Europe, IDAlert project, infectious disease, Joacim Rocklöv, Lancet Regional Health Journal, one health, zoonosis
(IN BRIEF) The European Union Commission has given the green light for the use of the adapted Comirnaty XBB.1.5 COVID-19 vaccine, developed by BioNTech-Pfizer, in Member States’ upcoming fall vaccination campaigns. This marks the third adaptation of the Comirnaty vaccine … Read the full press release
(IN BRIEF) Bayer is making a significant investment of EUR 220 million in research and development (R&D) at its Monheim site in Germany, focusing on its Crop Protection business. This represents the company’s largest single investment in Crop Protection in … Read the full press release
Posted in Agriculture, Business, Education, Environment, Financial, Germany, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Bayer, crop protection, Dr. Axel Trautwein, Dr. Robert Reiter, INNOVATION, investment, Rachel Rama, Regenerative Agriculture, sustainability
(IN BRIEF) Pfizer and BioNTech have received a recommendation for marketing authorization from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for their Omicron XBB.1.5-adapted monovalent COVID-19 vaccine. The recommendation includes the administration of a single … Read the full press release
Posted in Business, European Union, Germany, Government, Healthcare, Industrial, Management, Marketing, News, Pharma & Biotech, Science
Tagged Albert Bourla, BioNTech, Comirnaty, COVID-19 vaccine, EMA, Omicron XBB.1.5-Adapted, Pfizer, Prof. Ugur Sahin, Tozinameran
(IN BRIEF) EMA proposes Comirnaty Omicron XBB.1.5 vaccine for ages 6 months+, tailored to combat Omicron XBB.1.5 variant. One dose suffices for ages 5+, while kids 6 months to 4 years may need 1 or 3 doses based on prior … Read the full press release
(IN BRIEF) Pairwise and Bayer have entered into a new five-year, multi-million Dollar collaboration focusing on gene-edited short-stature corn. Building on their initial partnership for corn, soy, wheat, cotton, and canola, this collaboration aims to optimize and enhance gene-edited short-stature … Read the full press release
Posted in Agriculture, Business, Environment, Germany, Industrial, Management, News, Pharma & Biotech
Tagged Bayer, Bob Reiter, Gene-Edited Short-Stature Corn, Pairwise, partnership, Smart Agriculture, sustainability, Tom Adams
(IN BRIEF) Meningitis Research Foundation, the Confederation of Meningitis Organisations (CoMO), and Sanofi have united to introduce ‘The Meningitis Flag,’ a worldwide campaign aimed at increasing awareness in the fight against meningitis. The campaign, supported by para-athletes including Ellie Challis, … Read the full press release
Posted in Business, Education, France, Healthcare, Management, Marketing, Media, News, Pharma & Biotech, Science, Sports
Tagged 'The Meningitis Flag', awareness, Confederation of Meningitis Organisations (CoMO), Davide Morana, Ellie Challis, Global Campaign, meningitis, Meningitis Research Foundation, Paris 2024 Paralympic Games, partnership, Paul Hudson, Sanofi, Théo Curin, vaccination, Vinny Smith
(IN BRIEF) Sandoz, a global leader in generic and biosimilar medicines, has successfully acquired the worldwide brand rights for the systemic antifungal agent Mycamine® (micafungin sodium) from Astellas. This acquisition bolsters Sandoz’s position in the global hospital sector and enhances … Read the full press release
Posted in Business, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Switzerland
Tagged acquisition, Astellas, Mycamine®, Richard Saynor, Sandoz
(IN BRIEF) DHL Global Forwarding is experiencing a rising demand for sustainable transport solutions using fuels like Sustainable Aviation Fuels. More shippers are requesting emissions transparency and exploring sustainable options, even with extra costs. DHL’s GoGreen Plus service, which uses … Read the full press release
Posted in Aviation & Aerospace, Business, Energy, Gas & Oil, Environment, Germany, Industrial, Management, News, Pharma & Biotech, Transportation & Logistics
Tagged Decarbonize Air Freight, DHL, Dorethe Nielsen, GoGreen Plus service, Novo Nordisk, partnership, sustainability, Sustainable Aviation Fuels, sustainable transport solutions, Thomas George
(IN BRIEF) Pharmaceutical company Boehringer Ingelheim has declared its intention to move forward with survodutide, a dual agonist targeting the glucagon/GLP-1 receptors, into three Phase III clinical trials for individuals suffering from overweight or obesity. This decision stems from promising … Read the full press release
(IN BRIEF) AstraZeneca is advancing its lung cancer portfolio at the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer. The company is aiming to have an AstraZeneca medicine for over half of all … Read the full press release
Posted in Business, Education, Healthcare, Industrial, Management, Media, News, Pharma & Biotech, Science, United Kingdom
Tagged AstraZeneca, Dave Fredrickson, FLAURA2, IASLC Conference 2023, Lung Cancer Treatments, Susan Galbraith, Tagrisso (osimertinib), therapy, World Conference on Lung Cancer (WCLC)
(IN BRIEF) A recent study, conducted by a collaborative team including the University of Southampton and Imperial College London, has identified that individuals with compromised immune systems, such as those with solid organ transplants, rare autoimmune diseases, or blood cancer … Read the full press release
Posted in Business, Education, Healthcare, Management, News, Pharma & Biotech, Science, United Kingdom
Tagged blood cancer affecting lymphocytes, Dr Michelle Willicombe, Dr Peter Lanyon, Higher Risk, Immunocompromised Individuals, Imperial College London, Limited COVID-19 Antibodies, MELODY Study, Professor Sean Lim, rare autoimmune diseases, RESEARCH, solid organ transplants, University of Southampton, wellness
(IN BRIEF) Basilea Pharmaceutica Ltd, a biopharmaceutical company specializing in severe bacterial and fungal infection treatments, has announced robust financial results for the first half-year ending June 30, 2023. Their CEO, David Veitch, highlighted the company’s progress in executing their … Read the full press release
Posted in Business, Financial, Healthcare, Management, Marketing, News, Pharma & Biotech, Science, Switzerland
Tagged Adesh Kaul, Basilea Pharmaceutica, Cresemba®, David Veitch, financial results, Zevtera®
(IN BRIEF) BioNTech SE, a biopharmaceutical company, has appointed James Ryan as Chief Legal Officer (CLO) and a member of the Management Board, effective from September 1, 2023. In this role, Ryan will oversee the company’s corporate legal strategy, global … Read the full press release
Posted in Business, Germany, Industrial, Management, News, Pharma & Biotech, Science
Tagged appointment, BioNTech, Chief Legal Officer, Helmut Jeggle, James Ryan, leadership
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?